Login


Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

4 weeks ago
Read Full Article at Source
  3. Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

Related

Coca-Cola tops estimates, raises earnings outlook as global beverage demand rises

Coca-Cola tops estimates, raises earnings outlook as global beverage demand rises

Coca-Cola earnings are out – Here are the numbers

Coca-Cola earnings are out – Here are the numbers

UPS beats Wall Street estimates on top and bottom lines

UPS beats Wall Street estimates on top and bottom lines

GM raises 2026 guidance amid $500 million tariff refund, topping Wall Street's earnings expectations

GM raises 2026 guidance amid $500 million tariff refund, topping Wall Street's earnings expectations

Coca-Cola is about to report earnings. Here's what to expect

Coca-Cola is about to report earnings. Here's what to expect

General Motors is set to report earnings before the bell. Here's what Wall Street expects

General Motors is set to report earnings before the bell. Here's what Wall Street expects

Domino's Pizza stock falls on disappointing sales — and CEO thinks more chains will follow

Domino's Pizza stock falls on disappointing sales — and CEO thinks more chains will follow

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Spotify teams up with Peloton to launch global fitness content hub

Spotify teams up with Peloton to launch global fitness content hub

This bank CEO let his AI clone handle an earnings call — now he's signing an OpenAI deal

This bank CEO let his AI clone handle an earnings call — now he's signing an OpenAI deal

United Airlines CEO confirms he approached American Airlines about merger

United Airlines CEO confirms he approached American Airlines about merger

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Clock ticks on Spirit Airlines as bondholders weigh Trump bailout. Here's what could happen next

Clock ticks on Spirit Airlines as bondholders weigh Trump bailout. Here's what could happen next

FDA fast-tracks psychedelic drug research following Trump executive order

FDA fast-tracks psychedelic drug research following Trump executive order

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Spirit Airlines' cash won't 'last for very much longer,' but Trump says government could buy carrier

Spirit Airlines' cash won't 'last for very much longer,' but Trump says government could buy carrier

Procter & Gamble earnings beat estimates as sales grow 7%

Procter & Gamble earnings beat estimates as sales grow 7%

New York's pied-a-terre tax sets up legal fight over values

New York's pied-a-terre tax sets up legal fight over values

Login
Play Games    Shop Online   
Want to Advertise with us?
Terms & Conditions    Privacy Policy
About Us    Contact Us
POWERED BY MUDIT GUPTA VENTURES